Federal award
QUIDELORTHO SALES COMPANY, LLC
W81K0023P0168
Contract
Obligated and Ceiling
- Obligated (net)
- $498,561.96
- Ceiling (potential value, not spending)
- $827,313.00
- Current value
- $656,931.62
- Gross positive obligations
- $514,144.14
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0023P0168
- Award type code
- B
- Actions
- 9 · Jul 11, 2023 to May 19, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 19, 2026 | FY2026 | P00008 | G | $0.00 | — |
| Apr 1, 2026 | FY2026 | P00007 | C | −$11,322.98 | — |
| Dec 19, 2025 | FY2026 | P00006 | J | $170,381.38 | — |
| Apr 28, 2025 | FY2025 | P00005 | G | $0.00 | — |
| Jan 8, 2025 | FY2025 | P00004 | C | −$4,259.20 | — |
| Nov 19, 2024 | FY2025 | P00003 | C | $170,131.38 | — |
| May 29, 2024 | FY2024 | P00002 | G | $0.00 | — |
| Oct 31, 2023 | FY2024 | P00001 | C | $173,631.38 | — |
| Jul 11, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.